Related Experiment Video
Updated: Jul 28, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Partial exchange transfusion in sickle cell anemia. Use in children with serious complications
Insights
Partial exchange transfusions effectively improved hematocrit and reduced sickle hemoglobin in children with sickle cell anemia. This treatment led to significant clinical improvements for serious complications, including acute lung syndrome and liver crisis.
Area of Science:
- Pediatrics
- Hematology
- Transfusion Medicine
Background:
- Sickle cell anemia is a serious genetic blood disorder with severe complications.
- Partial exchange transfusion is a potential therapeutic option for managing sickle cell anemia complications.
Purpose of the Study:
- To evaluate the efficacy and safety of partial exchange transfusions in children with sickle cell anemia.
- To assess the impact of partial exchange transfusions on hematological parameters and clinical outcomes.
Main Methods:
- Seventeen children with sickle cell anemia underwent partial exchange transfusions.
- Each patient received two procedures at 24-hour intervals.
- Hematocrit and sickle hemoglobin levels were monitored pre- and post-transfusion.
Main Results:
- Mean hematocrit increased from 22.9% to 40.6%.
- Mean sickle hemoglobin decreased from 93.8% to 28.0%.
- Significant clinical improvements were observed in patients with acute lung syndrome and acute liver crisis.
Conclusions:
- Partial exchange transfusions are well-tolerated and effective in improving hematological parameters in pediatric sickle cell anemia patients.
- The procedure offers significant clinical benefits for severe sickle cell anemia complications.
- Exchange transfusions are a valuable therapeutic strategy for managing sickle cell disease.
Abstract:
Seventeen children with sickle cell anemia received 40 partial exchange transfusions for serious complications of sickle cell anemia, and preoperatively to reduce the risk of anesthesia. Each patient received two partial exchange transfusions at 24-hour intervals and all patients tolerated the exchange transfusions well. The mean hematocrit level rose from 22.9% before the exchange transfusion to 40.6% at the end of the second exchange. The mean sickle hemoglobin level decreased from 93.8% before the exchange to 28.0% after the second exchange. Patients with acute lung syndrome had remarkable improvement in clinical symptoms and PaO2 levels, and those with acute liver crisis had substantial reduction in serum bilirubin levels. All the other patients showed marked clinical improvement following the exchange transfusions.
More Related Videos
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
iPS Cell Differentiation
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction